Multiple Myeloma
News
Pesticides Linked to Precancerous Blood Disorder
(06/24/2009)
Individuals who apply pesticides to crops are twice as likely as the general population to develop a precancerous blood disorder called MGUS (monoclonal gammopathy of undetermined significance), which can lead to multiple myeloma, according to the results of a study published in Blood.
Formaldehyde Exposure May Increase Risk of Blood and Lymphatic Cancers
(06/23/2009)
Industrial workers who are exposed to formaldehyde may be at an increased risk of dying from blood and lymphatic cancers, particularly myeloid leukemia but also Hodgkin’s lymphoma and multiple myeloma, according to the results of a study published in the Journal of the National Cancer Institute.
Thalomid® Consolidation After Transplant Prolongs Survival in Multiple Myeloma
(04/27/2009)
One year of treatment with Thalomid® (thalidomide) and prednisone after a single autologous stem cell transplant prolongs survival in patients with newly diagnosed multiple myeloma, according to the results of a study published in the Journal of Clinical Oncology.
Green Tea May Negate the Benefits of Velcade®
(03/11/2009)
Consumption of green tea may be contraindicated for patients who are receiving treatment with Velcade® (bortezomib), as the polyphenols in green tea may actually negate the therapeutic benefits of the drug, according to the results of a study published in Blood.
Velcade® Combinations for Newly Diagnosed Patients with Multiple Myeloma at ASH 2008
(02/18/2009)
At the 2008 meeting of the American Society of Hematology (ASH) in December in San Francisco, there were several oral presentations on the outcomes of newly diagnosed patients with multiple myeloma where Velcade® (bortezomib) was incorporated into the induction regimen.
More
Multiple Myeloma
Cancer News...